Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Lixte Biotechnology Holdings (LIXT) is now available.
In a significant corporate update, the Company has announced the appointment of Dr. Jan Schellens as the new Chief Medical Officer, effective from June 3, 2024. This move could signal strategic shifts and expertise enhancement, capturing the attention of investors tracking leadership changes in the stock market.
Find detailed analytics on LIXT stock on TipRanks’ Stock Analysis page.